These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25460180)

  • 1. Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement.
    Kim H; Park SH; Kim EK; Kim MJ; Park YN; Park HJ; Choi JY
    PLoS One; 2014; 9(12):e114224. PubMed ID: 25460180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model.
    Xu J; Wang X; Jin ZY; You Y; Wang Q; Wang ST; Xue HD
    Chin Med Sci J; 2019 Mar; 34(1):24-32. PubMed ID: 30961777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
    Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
    Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S
    Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.
    Feier D; Balassy C; Bastati N; Stift J; Badea R; Ba-Ssalamah A
    Radiology; 2013 Nov; 269(2):460-8. PubMed ID: 23878281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.
    Park HJ; Lee SS; Park B; Yun J; Sung YS; Shim WH; Shin YM; Kim SY; Lee SJ; Lee MG
    Radiology; 2019 Feb; 290(2):380-387. PubMed ID: 30615554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
    Nojiri S; Kusakabe A; Fujiwara K; Shinkai N; Matsuura K; Iio E; Miyaki T; Joh T
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1032-9. PubMed ID: 23432660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers.
    Jang HJ; Min JH; Lee JE; Shin KS; Kim KH; Choi SY
    Abdom Radiol (NY); 2019 Aug; 44(8):2769-2780. PubMed ID: 31041497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: predictive value for liver function and pathology.
    Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Yoshizumi T; Hida T; Honda H
    Abdom Radiol (NY); 2016 Sep; 41(9):1751-7. PubMed ID: 27138437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS; Kim MJ; Lim JS; Hong HS; Chung YE; Choi JY
    Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.
    Leporq B; Daire JL; Pastor CM; Deltenre P; Sempoux C; Schmidt S; Van Beers BE
    Clin Sci (Lond); 2018 Apr; 132(7):813-824. PubMed ID: 29440620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Invest Radiol; 2012 Nov; 47(11):649-55. PubMed ID: 23011189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
    Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
    Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of histogram analysis of susceptibility-weighted MRI for staging of liver fibrosis.
    Yang ZX; Liang HY; Hu XX; Huang YQ; Ding Y; Yang S; Zeng MS; Rao SX
    Diagn Interv Radiol; 2016; 22(4):301-7. PubMed ID: 27113421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis.
    Choi YR; Lee JM; Yoon JH; Han JK; Choi BI
    Invest Radiol; 2013 Aug; 48(8):607-13. PubMed ID: 23538889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.